Liyuan Zhang

Liyuan Zhang

Auto-generated profile, based on publicly available information

Liyuan Zhang

Harvard John A. Paulson School of Engineering and Applied Sciences, Harvard University, c, MA 02138, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 January 2018 in Small
Verified
Journal Article
Closed access
PDF file
LZLiyuan Zhang
Liyuan Zhang
KCKaiwen Chen
Kaiwen Chen
HZHaoyue Zhang
Haoyue Zhang
BPBo Pang
Bo Pang
CCChang‐Hyung Choi
Chang‐Hyung Choi
DWDavid A Weitz
David A Weitz

21 June 2024 in Matter
Verified
Journal Article
Closed access
BLBo Li
Bo Li
LZLiyuan Zhang
Liyuan Zhang
YYYuan Yin
Yuan Yin
ACAnqi Chen
Anqi Chen
BSBo Ri Seo
Bo Ri Seo
DWDavid A Weitz
David A Weitz

9 November 2017 in Lab on a Chip
Verified
Journal Article
Closed access
PDF file
ACAnqi Chen
Anqi Chen
XGXue-Hui Ge
Xue-Hui Ge
JCJian Chen
Jian Chen
LZLiyuan Zhang
Liyuan Zhang
Jianhong XuJianhong Xu
Jianhong Xu
We developed a microfluidic approach to simultaneously incorporate various catalysts into the micromotor in a one-step process. This provides the micromotor with self-propelled, magnetic and water treatment functions, which should benefit a wide range of applications.

15 January 2024 in Lab on a Chip
Verified
Journal Article
Open access
PDF file
LRLingling Ren
Lingling Ren
SLShuang Liu
Shuang Liu
Junjie ZhongJunjie Zhong
Junjie Zhong
LZLiyuan Zhang
Liyuan Zhang
Microfluidic-enabled smart microcapsules as delivery systems from droplet fabrication to tailored delivery and controlled release.

1 February 2022 in Nanoscale
Verified
Journal Article
Closed access
PDF file
ZLZhijun Li
Zhijun Li
KJKun Jin
Kun Jin
HCHong Chen
Hong Chen
LZLiyuan Zhang
Liyuan Zhang
GZGuitao Zhang
Guitao Zhang
XQXiangmeng Qu
Xiangmeng Qu
We present a machine learning approach-based array sensor for high-accuracy profiling of mechanisms of action (MoAs) by sensing the physicochemical changes on surfaces of bacteria. We successfully predict the MoAs of 4 antimicrobial compounds and a novel small molecule AMP.

25 December 2021 in Bioactive Materials
Verified
Journal Article
Open access
BLBo Li
Bo Li
XLXin Li
Xin Li
XCXiaodong Chu
Xiaodong Chu
PLPengcheng Lou
Pengcheng Lou
YYYin Yuan
Yin Yuan
ZWZhongwen Wu
Zhongwen Wu
In-situ oral delivery of therapeutic antibodies, like monoclonal antibody, for chronic inflammation treatment is the most convenient approach compared with other administration routes. Moreover, the abundant links between the gut microbiota and colonic inflammation indicate that the synergistic or antagonistic effect of gut microbiota to colonic inflammation. However, the antibody activity would be significantly affected while transferring through the gastrointestinal tract due to hostile conditions. Moreover, these antibodies have short serum half-lives, thus, require to be frequently administered with high doses to be effective, leading to low patient tolerance. Here, we develop a strategy utilizing thin shell hydrogel microcapsule fabricated by microfluidic technique as the oral delivering carrier. By encapsulating antibodies in these microcapsules, antibodies survive in the hostile gastrointestinal environment and rapidly release into the small intestine through oral administration route, achieving the same therapeutic effect as the intravenous injection evaluated by a colonic inflammation disease model. Moreover, the abundance of some intestinal microorganisms as the indication of the improvement of inflammation has remarkably altered after in-situ antibody-laden microcapsules delivery, implying the restoration of micro-ecology of the intestine. These findings prove our microcapsules are exploited as an efficient oral delivery agent for antibodies with programmable function in clinical application.